About 400 reports

  • Acute Myeloid Leukemia Therapeutics
  • Acute Myeloid Leukemia Therapeutics Market: Market

The global acute myeloid leukemia market is expected to register a CAGR of 14% during the forecast period of 2018-2023. Due to the higher awareness of the condition and the drugs that treat it, and continued acceptance toward existing therapeutics, North America dominates the market studied. High Incidence and Prevalence of Acute Myeloid...

  • Leukemia
  • Celgene Corporation
  • Eisai Co., Ltd.
  • Genmab group
  • Novartis AG
  • Leukemia Treatment Drugs Supply and Demand
  • Leukemia Treatment Drugs Capacity in China

China’s demand for Leukemia Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...

  • Leukemia
  • China
  • Supply
  • Tianjin Tianyao Pharmaceutical Co., Ltd
  • Zhejiang Expressway Co., Ltd.
  • Leukemia Treatment Drugs Supply and Demand
  • Leukemia Treatment Drugs Classification, Output and

This study focuses on China’s Leukemia Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s...

  • Leukemia
  • China
  • Demand
  • Market Size
  • Supply
  • Acute lymphocytic leukemia market in EMEA
  • Acute lymphocytic leukemia market in Americas

Global Acute Lymphocytic Leukemia Market 2015-2019 Covering: An in-depth study of the acute lymphocytic leukemia market and segmentation by route of administration (oral and parenteral), by type of molecules (biologics and small molecules), and by geography (the Americas, EMEA, and APAC). The report also presents a detailed analysis of...

  • Leukemia
  • United States
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Novartis AG

Global Chronic Myelogenous Leukemia Treatment Market: Market Segmentation The global chronic myelogenous leukemia treatment market has been segmented into type of treatment, distribution channel, drug type and region.

  • Healthcare
  • Leukemia
  • Therapy
  • World
  • Market Size
  • Leukemia Treatment Drugs Industry Capacity
  • Leukemia Treatment Drugs Supply and Demand

This study focuses on China’s Leukemia Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy....

  • Leukemia
  • China
  • Nanjing Aosaikang Medicinal Group
  • Zhejiang Expressway Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

Global Chronic Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017 ##.

  • Leukemia
  • France
  • United States
  • World
  • Forecast

Global Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017 ##.

  • Leukemia
  • France
  • United States
  • World
  • Forecast
  • 6.7 ACUTE PROMYELOCYTIC LEUKEMIA
  • TREATMENT GUIDELINES FOR ACUTE MYELOID LEUKEMIA

OpportunityAnalyzer: Acute Myeloid Leukemia - Opportunity Analysis and Forecasts to 2026 Summary Acute myeloid leukemia (AML) is a rapidly progressing blood cancer with a poor overall prognosis. AML is relatively rare, and predominantly affects older adults. Although a number of acquired genetic and molecular abnormalities...

  • Leukemia
  • Astellas Pharma Inc.
  • Astex Pharmaceuticals, Inc.
  • Celgene Corporation
  • Novartis AG

Based on leukemia type the market is categorized into chronic leukemia, acute leukemia, chronic myeloid leukemia, acute myeloid leukemia, chronic myelogenous leukemia, acute myelogenous leukemia, chronic lymphatic leukemia, and

  • Leukemia
  • United States
  • World
  • Forecast
  • Market Size
  • 2.2 UPCOMING REPORTS
  • 4.1 BIBLIOGRAPHY

EpiCast Report: Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2025 Summary Chronic lymphocytic leukemia (CLL), also known as chronic lymphoid leukemia, is a type of cancer of the white blood cells (lymphocytes). CLL affects a particular lymphocyte, the B cell, which accumulates mainly in...

  • Leukemia
  • Canada
  • Italy
  • United States
  • Forecast

Chronic Lymphocytic Leukemia Phase ## Clinical Trials, 2016 ##.

  • Leukemia
  • France
  • United States
  • Market Shares
  • Market Size

Hairy Cell Leukemia Phase ## Clinical Trials, 2016 ##.

  • Leukemia
  • France
  • United States
  • Market Shares
  • Market Size

Chronic Myeloid Leukemia Phase ## Clinical Trials, 2016 ##.

  • Leukemia
  • France
  • United States
  • Market Shares
  • Market Size

Acute lymphocytic Leukemia Phase ## Clinical Trials, 2016 ##.

  • Leukemia
  • France
  • United States
  • Market Shares
  • Market Size

Acute Myeloid Leukemia Phase ## Clinical Trials, 2016 ##.

  • Leukemia
  • France
  • United States
  • Market Shares
  • Market Size
  • Acute Myeloid Leukemia: Executive Summary
  • 4.1 BIBLIOGRAPHY

EpiCast Report: Acute Myeloid Leukemia - Epidemiology Forecast to 2026 Summary Acute Myeloid Leukemia (AML), also known as myelogenous leukemia, acute myelocytic leukemia, or acute nonlymphocytic leukemia, is a rare cancer that accounts for a disproportionally high number of cancer-related deaths. The disease is more...

  • Leukemia
  • Italy
  • Japan
  • United States
  • Forecast
  • FORECAST: CHRONIC MYELOID LEUKEMIA
  • Forecast: Chronic Myeloid Leukemia

Sprycel and Tasigna continue to compete for market share in second-line CML as generic imatinib begins to supersede Gleevec in all markets. This report addresses the following questions: - What are the biggest unmet needs in the CML market? - What are the current pipeline trends in the CML market and how do they compare...

  • Leukemia
  • United States
  • ARIAD Pharmaceuticals, Inc.
  • Novartis AG
  • Pfizer Inc.

Acute Lymphocytic/ Lymphoblastic Leukemia Therapeutics Market Analysis By Therapy And Segment Forecasts, 2014 - 2025 Chapter ## Research Methodology & Scope ##. ## Region Wise Market Calculation ##. ##. ## Region-wise market: Base Estimates ##. ##. ## Global Market: CAGR Calculation ##. ##

  • Cancer
  • Leukemia
  • Therapy
  • United States
  • Market Size
  • EPIDEMIOLOGY: ACUTE LYMPHOBLASTIC LEUKEMIA
  • FORECAST: ACUTE LYMPHOBLASTIC LEUKEMIA

The entry of CAR-T therapies will offset the generic erosion of the TKI class to drive huge growth in the acute lymphoblastic leukemia (ALL) market. This report addresses the following questions: - In which treatment settings are chimeric antigen receptor T-cell (CAR-T) therapies being developed and how well are they expected...

  • Leukemia
  • Amgen Inc.
  • ARIAD Pharmaceuticals, Inc.
  • Novartis AG
  • Pfizer Inc.

Global Acute Lymphocytic Leukemia Market: Trend Analysis and Forecast to 2022. ##.

  • Leukemia
  • United States
  • World
  • Forecast
  • Market Size

Europe Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017 ##.

  • Leukemia
  • Europe
  • France
  • Germany
  • Italy

Europe Chronic Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017 ##.

  • Leukemia
  • Europe
  • France
  • Germany
  • Italy
  • TYPE OF LEUKAEMIA
  • LYMPHOCYTIC LEUKAEMIA

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Leukaemia in 18 Major Markets Leukaemia refers to a group of cancers which originate in the bone marrow; they result in the overproduction of abnormal white blood cells. This limits the bone marrows ability to produce normal and fully mature white blood cells....

  • Cancer
  • Leukemia
  • Pathology

Hairy Cell Leukemia - Epidemiology Forecast to 2027 ##.

  • Leukemia
  • France
  • Germany
  • Italy
  • Spain

Chronic Lymphocytic Leukemia (CLL) -Epidemiology Forecast to 2027 ##.

  • Leukemia
  • France
  • Germany
  • Italy
  • Spain

Chronic Myelocytic Leukemia (CML) -Epidemiology Forecast to 2027 ##.

  • Leukemia
  • France
  • Germany
  • Italy
  • Spain

Acute Myeloid Leukemia (AML) -Epidemiology Forecast to 2027 ##.

  • Leukemia
  • France
  • Germany
  • Italy
  • Spain

Acute Lymphoblastic Leukemia (ALL) -Epidemiology Forecast to 2027 ##.

  • Leukemia
  • France
  • Germany
  • Italy
  • Spain

Drug A: Company ## ##. ##. ##.

  • Cancer
  • Leukemia
  • United States
  • Market Shares